The future belongs to dreamers.
Far Out
As the taboo on consciousness-altering therapeutics lifts, psychedelics are gaining federal support, TMS clinics are scaling, and lucid dreaming is moving from fringe to funded.
At the intersection of the $25B sleep tech market and the $17B neurotech sector, a new batch of companies wants to engineer dreams for human flourishing.
Waking Life
Appearing throughout history, ancient cultures leveraged dream manipulation for psychological insight, while Edison, Tesla, Poe, and Dalí hacked dream states for inspiration.
Altering dreams may boost creativity, mood, learning, and athletic performance while also showing potential for treating PTSD and depression.
Tapping modern neuroscience, lucidity may be inducible by activating brain regions tied to self-awareness, with two techniques emerging:
- Targeted Dream Incubation: Pioneered at MIT Media Lab, TDI delivers auditory cues during hypnagogia (sleep onset), steering dreams with up to 92% success rates.
- Transcranial focused ultrasound: Requiring specialized hardware, tFUS noninvasively stimulates the brain with low-intensity sound waves, a method also used to study consciousness.
Inception
Moving from lab to product, Prophetic just launched DTC headbands (costing $449–$1,299), pairing EEG sensors with targeted tFUS. Backed by BoxGroup and a16z’s Scout Fund, early tests show increased dream recall, clarity, and control, but peer-reviewed studies are still needed.
Teaching the trade, Dust Systems developed a TDI app, doing for dreams what Headspace did for meditation and Open for breathwork. Founded by an MIT researcher, it offers ready-made or custom dream incubations plus education on topics like yoga nidra and nightmare rescripting.
Takeaway: Continuous brain monitoring infrastructure is coming, and dream tech adds another layer. Following the mainstreaming of yoga, meditation, breathwork, and psychedelics, engineering dreams is the next step in the West’s consciousness exploration arc.
